Changchun BCHT Biotechnology Co (SHSE:688276) Cash-to-Debt : 4.44 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Changchun BCHT Biotechnology Co's cash to debt ratio for the quarter that ended in Sep. 2024 was 4.44.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Changchun BCHT Biotechnology Co could pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Changchun BCHT Biotechnology Co's Cash-to-Debt or its related term are showing as below:

SHSE:688276' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.28 Med: No Debt Max: No Debt
Current: 4.44

During the past 7 years, Changchun BCHT Biotechnology Co's highest Cash to Debt Ratio was No Debt. The lowest was 1.28. And the median was No Debt.

SHSE:688276's Cash-to-Debt is ranked better than
69.44% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs SHSE:688276: 4.44

Changchun BCHT Biotechnology Co Cash-to-Debt Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Changchun BCHT Biotechnology Co Cash-to-Debt Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

1.65

No Debt

21.60

Changchun BCHT Biotechnology Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	21.60	6.00	3.35	4.44

Competitive Comparison of Changchun BCHT Biotechnology Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun BCHT Biotechnology Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Changchun BCHT Biotechnology Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun BCHT Biotechnology Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Changchun BCHT Biotechnology Co's Cash-to-Debt falls into.

Changchun BCHT Biotechnology Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Changchun BCHT Biotechnology Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	442.18	/	(20.472	+	0)
	=	21.60

Changchun BCHT Biotechnology Co's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	277.89	/	(25.809	+	36.773)
	=	4.44

Changchun BCHT Biotechnology Co (SHSE:688276) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Changchun BCHT Biotechnology Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Changchun BCHT Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co Headlines

No Headlines